Methimazole and carbimazole are first-line drug treatments for feline hyperthyroidism with welfare implications for long-term management.
Drug treatment manages hyperthyroid welfare effectively when compliance is achieved but lifelong twice-daily dosing is challenging. Cats that resist tablet administration experience repeated stress during medication. Exploring alternative treatment routes (transdermal gels) or curative treatments improves long-term welfare.